Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| type I pneumocyte | 11 studies | 33% ± 11% | |
| epithelial cell | 10 studies | 28% ± 13% | |
| goblet cell | 9 studies | 32% ± 13% | |
| ciliated cell | 9 studies | 33% ± 10% | |
| respiratory goblet cell | 8 studies | 25% ± 12% | |
| club cell | 7 studies | 39% ± 17% | |
| type II pneumocyte | 6 studies | 31% ± 8% | |
| secretory cell | 6 studies | 29% ± 8% | |
| squamous epithelial cell | 4 studies | 42% ± 18% | |
| basal cell | 3 studies | 39% ± 2% | |
| enterocyte | 3 studies | 30% ± 8% | |
| luminal cell of prostate epithelium | 3 studies | 23% ± 5% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| pancreas | 96% | 475.90 | 314 / 328 | 92% | 64.96 | 163 / 178 |
| prostate | 87% | 876.13 | 214 / 245 | 96% | 32.57 | 484 / 502 |
| lung | 97% | 1723.26 | 563 / 578 | 80% | 40.92 | 923 / 1155 |
| stomach | 79% | 3357.89 | 282 / 359 | 92% | 46.95 | 262 / 286 |
| intestine | 48% | 1685.51 | 463 / 966 | 96% | 53.96 | 508 / 527 |
| bladder | 57% | 865.05 | 12 / 21 | 74% | 31.11 | 373 / 504 |
| breast | 53% | 310.72 | 245 / 459 | 72% | 15.36 | 802 / 1118 |
| kidney | 98% | 633.17 | 87 / 89 | 25% | 4.52 | 228 / 901 |
| esophagus | 39% | 836.05 | 559 / 1445 | 68% | 39.04 | 125 / 183 |
| ureter | 0% | 0 | 0 / 0 | 100% | 28.28 | 1 / 1 |
| thymus | 2% | 4.52 | 12 / 653 | 76% | 50.50 | 462 / 605 |
| skin | 72% | 853.99 | 1303 / 1809 | 5% | 0.57 | 23 / 472 |
| tonsil | 0% | 0 | 0 / 0 | 58% | 16.04 | 26 / 45 |
| uterus | 2% | 18.08 | 3 / 170 | 53% | 18.39 | 244 / 459 |
| ovary | 18% | 54.88 | 32 / 180 | 21% | 3.38 | 92 / 430 |
| peripheral blood | 19% | 230.66 | 176 / 929 | 0% | 0 | 0 / 0 |
| liver | 3% | 7.18 | 7 / 226 | 12% | 3.41 | 47 / 406 |
| blood vessel | 14% | 33.78 | 181 / 1335 | 0% | 0 | 0 / 0 |
| adrenal gland | 3% | 10.10 | 9 / 258 | 7% | 1.39 | 17 / 230 |
| spleen | 9% | 22.42 | 22 / 241 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 3% | 0.25 | 1 / 29 |
| heart | 3% | 7.48 | 29 / 861 | 0% | 0 | 0 / 0 |
| brain | 2% | 7.76 | 62 / 2642 | 0% | 0.02 | 1 / 705 |
| adipose | 2% | 6.31 | 23 / 1204 | 0% | 0 | 0 / 0 |
| muscle | 0% | 0.46 | 2 / 803 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0006654 | Biological process | phosphatidic acid biosynthetic process |
| GO_0016042 | Biological process | lipid catabolic process |
| GO_0005615 | Cellular component | extracellular space |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0008201 | Molecular function | heparin binding |
| GO_0004620 | Molecular function | phospholipase activity |
| GO_0052689 | Molecular function | carboxylic ester hydrolase activity |
| GO_0005515 | Molecular function | protein binding |
| Gene name | LIPH |
| Protein name | Lipase member H (LIPH) (EC 3.1.1.-) (LPD lipase-related protein) (Membrane-associated phosphatidic acid-selective phospholipase A1-alpha) (mPA-PLA1 alpha) (Phospholipase A1 member B) Lipase H |
| Synonyms | MPAPLA1 PLA1B LPDLR |
| Description | FUNCTION: Hydrolyzes specifically phosphatidic acid (PA) to produce 2-acyl lysophosphatidic acid (LPA; a potent bioactive lipid mediator) and fatty acid. Does not hydrolyze other phospholipids, like phosphatidylserine (PS), phosphatidylcholine (PC) and phosphatidylethanolamine (PE) or triacylglycerol (TG). . |
| Accessions | Q8WWY8 A2IBA6 ENST00000296252.9 H7BZL3 ENST00000429510.1 ENST00000435679.1 ENST00000424591.6 F8WE09 H7C2X1 ENST00000452897.1 A2IBA8 |